Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Ozon came to Georgia

9/10/24 OZON

Sberbank reported on RAS for August

9/10/24 SBER

Home Bank valuation revised again in favor of the buyer

9/10/24 SVCB

Shareholders of Territorial Generating Company № 14 approved dividends

9/10/24 TGKN

Perekrestok will charge electric cars

9/9/24 X5

Shareholders of IMCB approved dividends

9/9/24 GEMA

En+ Group wants to abandon part of TPP modernization projects

9/9/24 ENPG

SPX Exchange listed 85 more shares of Russian companies

9/9/24 SPBE

Softline attracted a new institutional investor

9/9/24 SOFL

INGRAD reported for the 6 months of 2024 by RAS

9/6/24 INGR